Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device.
Single doses of one, three, and six actuations (120 micro g albuterol/actuation) and multiple daily doses (six actuations per dose four times daily) for 5 days of aerosol albuterol sulfate were sequentially administered to each of six horses using an equine inhaler device (Torpex, 3M Animal Care Products, St. Paul, MN [corrected] and Boehringer Ingleheim Vetmedica, Inc., St. Joseph, MO [corrected]). A 2-week washout period was allowed between each dose. ELISA testing revealed no evidence of albuterol in urine at 24 hours after any single-dose administration. Results indicated that 48 hours or longer should be allowed for albuterol to be cleared from urine after single doses. When given at the maximum recommended rate of six actuations per dose four times a day for 5 days, urine samples tested by ELISA showed no evidence of albuterol at 48 hours after the final dose. Testing of nasal swabs by ELISA demonstrated the presence of albuterol for 8 hours after each single dose, and some horses might have detectable levels of albuterol in nasal swabs for several days following administration of multiple doses. As a guideline for withdrawal time, 72 hours or longer should be allowed after administration of aerosol albuterol sulfate to horses before participation in equestrian competitions that are regulated for detection of certain performance-enhancing substances. However, these recommendations were based on a small sample of horses and the specific ELISA test used and interpreted as described. Factors specific to individual horses may influence these detection times.
Dirikolu
Levent
L
University of Kentucky, Department of Veterinary Science, Lexington, KY 40546, USA.
Mollett
Brad A
BA
Troppmann
Amy
A
Woods
William E
WE
Bratton
Calvert
C
Cashman
Conor P
CP
Schroedter
Dwight
D
Mayer
Brent
B
Lehner
Andreas F
AF
Karpiesiuk
Wojciech
W
Hughes
Charlie
C
Boyles
Jeff
J
Harkins
John D
JD
Tobin
Thomas
T
D000280:Administration, Inhalation; D000336:Aerosols; D000420:Albuterol / Q000008:administration & dosage* / Q000032:analysis* / Q000097:blood / Q000652:urine; D000818:Animals; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000032:analysis* / Q000097:blood / Q000652:urine; D003429:Cross Reactions; D004300:Doping in Sports; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D006736:Horses; D009330:Nebulizers and Vaporizers / Q000662:veterinary*; D012015:Reference Standards; D012680:Sensitivity and Specificity; D013997:Time Factors
D000336:Aerosols; D001993:Bronchodilator Agents; D000420:Albuterol